IP Library Granted Patent US 10,260,077
Granted Patent B2
US 10,260,077 · App. 15/312,852 · Granted Apr 16, 2019

Increasing lipid production in oleaginous yeast

Inventors: Vasiliki Tsakraklides (Lexington, MA); Elena E. Brevnova (Belmont, MA)
Assignee: Novogy, Inc.
C12P7/6463C12N9/1025C12N9/1029C12N9/20C12Y203/0102C12Y301/01003
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,260,077
App. No.
15/312,852
Granted
Apr 16, 2019
Kind
B2
Abstract

Disclosed are methods and compositions for increasing the triacylglycerol content of a cell by increasing the activity of a type 1 diacylglycerol acyltransferase (i.e., DGA2) and increasing the activity of a type 2 diacylglycerol acyltransferase (i.e., DGA1). In some embodiments, the triacylglycerol content of a cell is also modified by decreasing the activity of a triacylglycerol lipase in the same cell. Also disclosed are methods and compositions for increasing the triacylglycerol content of a cell by increasing the activity of a type 1 diacylglycerol acyltransferase (i.e., DGA2), or by increasing the activity of a type 3 diacylglycerol acyltransferase (i.e., DGA3).

Claims (9)

1. A transformed Arxula or Yarrowia cell, comprising a nucleic acid molecule encoding a heterologous type 1 diacylglycerol acyltransferase protein from Claviceps ; and

a nucleic acid molecule encoding a heterologous type 2 diacylglycerol acyltransferase protein from Rhodosporidium,

wherein the transformed Arxula or Yarrowia cell does not express a triacylglycerol lipase protein and wherein the transformed Arxula or Yarrowia cell has a higher lipid content than a non-transformed cell of the same species.

2. The transformed cell of claim 1 , wherein said heterologous type 1 diacylglycerol acyltransferase protein is from Claviceps purpurea.

3. The transformed cell of claim 1 , wherein said heterologous type 2 diacylglycerol acyltransferase protein is from Rhodosporidium toruloides.

4. The transformed cell of claim 1 , wherein said triacylglycerol lipase is encoded by an endogenous TGL3 gene.

5. The transformed cell of claim 1 , wherein said cell is Yarrowia lipolytica and said triacylglycerol lipase comprises SEQ ID NO:41, or said triacylglycerol lipase is encoded by a nucleotide sequence comprising SEQ ID NO:42.

6. The transformed cell of claim 1 , wherein said cell is selected from the group consisting of Arxula adeninivorans and Yarrowia lipolytica.

7. The cell of claim 4 , wherein the transformed Yarrowia cell does not express a triacylglycerol lipase protein due to a deletion of a TGL3 gene.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 054142 FRAME: 0171. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Nov 17, 2020
From: NOVOGY, INC.
To: GINKGO BIOWORKS, INC.
Reel/Frame 054451/0918 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2020
From: NOVOGY, INC.
To: GINKGO BIOWORKS, INC
Reel/Frame 054142/0171 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2017
From: TSAKRAKLIDES, VASILIKI; BREVNOVA, ELENA E.
To: NOVOGY, INC.
Reel/Frame 041275/0318 →
Continuity (4)
Provisional Application 62090169 · Dec 10, 2014
Provisional Application 62033853 · Aug 6, 2014
Provisional Application 62004502 · May 29, 2014
Related Publication 20170191093A1 · Jul 6, 2017